STATE STREET CORP - ADURO BIOTECH INC ownership

ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 64 filers reported holding ADURO BIOTECH INC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ADURO BIOTECH INC
ValueSharesWeighting
Q3 2020$3,268,000
+7.5%
1,344,833
+2.2%
0.00%
Q2 2020$3,039,000
-7.2%
1,315,799
+10.1%
0.00%
Q1 2020$3,274,000
+131.2%
1,194,766
-0.4%
0.00%
Q4 2019$1,416,000
+3.7%
1,199,939
-6.8%
0.00%
Q3 2019$1,365,000
-28.1%
1,287,888
+4.5%
0.00%
Q2 2019$1,898,000
-56.9%
1,232,591
+11.4%
0.00%
Q1 2019$4,402,000
+50.3%
1,105,969
-0.3%
0.00%
Q4 2018$2,929,000
-63.8%
1,109,546
+0.8%
0.00%
-100.0%
Q3 2018$8,092,000
+9.3%
1,100,529
+4.1%
0.00%0.0%
Q2 2018$7,403,000
+3.1%
1,057,192
+36.9%
0.00%0.0%
Q1 2018$7,181,000
-45.4%
772,212
-56.0%
0.00%0.0%
Q4 2017$13,151,000
-13.7%
1,753,168
+22.5%
0.00%0.0%
Q3 2017$15,247,000
+95.3%
1,431,659
+109.1%
0.00%0.0%
Q2 2017$7,808,000
+14.9%
684,699
+8.3%
0.00%0.0%
Q1 2017$6,795,000
+3.8%
632,102
+10.2%
0.00%0.0%
Q4 2016$6,544,000
-7.0%
573,804
+1.3%
0.00%0.0%
Q3 2016$7,038,000
+14.5%
566,207
+4.2%
0.00%0.0%
Q2 2016$6,147,000
+198.1%
543,514
+237.9%
0.00%
Q1 2016$2,062,000
-39.4%
160,860
+33.0%
0.00%
Q4 2015$3,402,000
+92.1%
120,908
+32.4%
0.00%
Q3 2015$1,771,000
-19.1%
91,287
+26.5%
0.00%
Q2 2015$2,188,00072,1830.00%
Other shareholders
ADURO BIOTECH INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 5,118,560$12,438,0000.72%
Rubric Capital Management LP 1,629,321$3,959,0000.37%
Burrage Capital Management LLC 135,898$330,0000.26%
Artal Group S.A. 902,500$2,193,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,141,278$2,773,0000.05%
Point72 Asset Management, L.P. 2,050,000$4,982,0000.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 567,181$1,378,0000.01%
GSA CAPITAL PARTNERS LLP 34,241$83,0000.01%
Renaissance Technologies 4,384,010$10,653,0000.01%
ACADIAN ASSET MANAGEMENT LLC 802,749$1,951,0000.01%
View complete list of ADURO BIOTECH INC shareholders